Connection

Kenneth Dinnon to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Kenneth Dinnon has written about Antibodies, Viral.
Kenneth Dinnon
Connection Strength
0.043
Antibodies, Viral
  1. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2. Cell. 2020 11 25; 183(5):1367-1382.e17.
    View in: PubMed
    Score: 0.022
  2. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity. 2021 08 10; 54(8):1869-1882.e6.
    View in: PubMed
    Score: 0.006
  3. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun. 2021 06 11; 12(1):3587.
    View in: PubMed
    Score: 0.006
  4. A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine. Proc Natl Acad Sci U S A. 2020 12 22; 117(51):32657-32666.
    View in: PubMed
    Score: 0.005
  5. CD-loop Extension in Zika Virus Envelope Protein Key for Stability and Pathogenesis. J Infect Dis. 2017 12 05; 216(10):1196-1204.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.